Filing Details

Accession Number:
0001209191-15-069558
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-03 19:23:42
Reporting Period:
2015-09-02
Filing Date:
2015-09-03
Accepted Time:
2015-09-03 19:23:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1394319 Tracon Pharmaceuticals Inc. TCON Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1590442 Partnership Limited Investment V3 Super Jafco Otemachi First Square, West Tower 11F
1-5-1 Otemachi, Chiyoda-Ku
Tokyo M0 100-0004
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-09-02 7,300 $10.54 1,748,052 No 4 S Direct
Common Stock Disposition 2015-09-03 8,000 $10.49 1,740,052 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $10.45 to $10.61. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  2. This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $10.40 to $10.63. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.